Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

TL;DR - A Nature news item reports promising trial results for Moderna’s personalized cancer vaccine in preventing melanoma recurrence. The findings suggest cancer vaccines could potentially be adapted to target other tumour types.

• The treatment is personalized to an individual patient’s cancer.
• Trial results indicate that vaccination may reduce melanoma recurrence.
• The report highlights possible expansion to other cancers, but provides no efficacy figures or trial-design details.